Sophie Stroeks is a PhD candidate at the Department of Cardiology at Maastricht University under the supervision of Prof. Dr. Stephane Heymans and Dr. Miranda Nabben. She is focussing on cardiogenetics and specifically on truncating variants in the titin gene.
Sophie Stroeks received her bachelor degree in Biomedical Sciences in 2016 and her master degree Physician-Clinical Research in 2020 from Maastricht University. During her clinical rotations her interest in genetics increased and she joined the department of Clinical Genetics at the Maastricht University Medical Centre as a medical student. For her final research internship she re-joined the Yu lab at Harvard Medical School where she has been working on the development of fully personalized genomic therapy using antisense oligonucleotides as a treatment of rare, and fatal neurodegenerative disorders in children. After her master, she started working as a clinical and pre-clinical PhD-student in the research group of Prof. Dr. Heymans. She is focussing on cardiogenetics. Specifically, on truncating variants in the titin gene and the effects on metabolism in iPSCs.